Capricor Therapeutics Securities Lawsuit: Application Deadline September 28, 2026
The deadline to apply as a lead plaintiff in a securities class action lawsuit against Capricor Therapeutics, Inc. is September 28, 2026. Kahn Swick & Foti, LLC is notifying investors.
Investors in Capricor Therapeutics, Inc. (NasdaqGS: CAPR) have until September 28, 2026, to file an application to be a lead plaintiff in a securities class action lawsuit. The law firm Kahn Swick & Foti, LLC (KSF), along with partner Charles C. Foti, Jr., former Attorney General of Louisiana, has notified investors of the upcoming deadline.
The lawsuit alleges that Capricor and its executives made materially false or misleading statements regarding the Company's business and future prospects during a specified period. This period is defined by securities laws for such class action claims. Specific details about the allegations and the relevant timeframe are available through the law firm.
Individuals who purchased Capricor securities during the defined class period and suffered a loss may be eligible to serve as a lead plaintiff. The lead plaintiff plays a significant role in overseeing the litigation and potential settlement negotiations.
Interested parties are encouraged to contact KSF before the September 28, 2026 deadline to learn more about their rights and the application process.